Bio

An innovative Technical Operations and Quality leader in the pharmaceutical/biotech industry with over 20 years of experience encompassing gene therapies, vaccines, sterile injectables, small molecules, adjuvants and medical devices. Has successfully executed multiple process scale-ups/technical transfers from process development into a GMP facility in small molecule manufacturing (Eli Lilly), vaccines (Novartis) and gene therapies (Affinia). Has also delivered $1.8B USD of greenfield cGMP manufacturing facilities from design through FDA/EMA licensure.